Similar Items: Analysis of Somatic Mutations and Immunotherapy Biomarkers in Chinese Patients With Non‐Small Cell Lung Cancer During 2019–2024: A Retrospective Study
- Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer
- Co‐Designing Lung Cancer Rehabilitation Services for People Treated With Immunotherapy
- Cancer, collapse, and the politics of somatic evolution
- Rationale and Design of the Cancer Immunotherapy Evidence Living (CIEL) Library: A Continuously Updated Clinical Trial Database of Cancer Immunotherapies
- Efficacy and Safety of Acupuncture for Pain in Non-Small Cell Lung Cancer: A Meta-Analysis
- Panorama: a database for the oncogenic evaluation of somatic mutations in pan-cancer